コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Eligible patients had a first clinical demyelinating event wi
2 Eligible patients had a history of peripheral artery disease
3 Eligible patients had a nonischemic electrocardiogram determi
4 Eligible patients had a predicted mortality greater than or e
5 Eligible patients had a proximal arterial occlusion in the an
6 Eligible patients had a streptococcal PJI that was managed wi
7 Eligible patients had a WHO performance status of 0-2, had a
8 Eligible patients had adequate end-organ function, an Eastern
9 Eligible patients had at least two 4-6 HLA-identical UCBs wit
10 Eligible patients had baseline office systolic blood pressure
11 Eligible patients had been enrolled at one centre in the AURA
12 Eligible patients had biopsy-proven oesophageal cancer that w
13 Eligible patients had chemotherapy-sensitive relapsed/persist
14 Eligible patients had clinical splenomegaly poorly controlled
15 Eligible patients had clinical-stage T3 rectal adenocarcinoma
16 Eligible patients had confirmed stage IIIB or IV NSCLC with s
17 Eligible patients had diffuse large-B-cell lymphoma, no evide
18 Eligible patients had disease progression during or within 6
19 Eligible patients had had laboratory-confirmed EVD and had th
20 Eligible patients had HER2-positive advanced gastric cancer a
21 Eligible patients had histologically confirmed locally advanc
22 Eligible patients had histologically proven urothelial carcin
23 Eligible patients had HIV-1 RNA concentrations of at least 10
24 Eligible patients had IVT started within 4.5 hours of stroke
25 Eligible patients had locally advanced basal cell carcinoma n
26 Eligible patients had locally advanced NSCLC and no contraind
27 Eligible patients had low performance on hand grip strength a
28 Eligible patients had measurable disease (per RECIST version
29 Eligible patients had metastatic prostate cancer and a PSA le
30 Eligible patients had newly diagnosed glioblastoma confirmed
31 Eligible patients had one or more target lesions located in a
32 Eligible patients had pathological stage high-grade T1b or gr
33 Eligible patients had progressed on or after, or been intoler
34 Eligible patients had received up to three previous lines of
35 Eligible patients had stable angina pectoris, unstable angina
36 Eligible patients had stable or unstable angina or documented
37 Eligible patients had stage IV lung adenocarcinoma, had ROS1
38 Eligible patients had symptomatic, advanced stage follicular
39 Eligible patients had to be aged 65 years or older, have age-
46 All patients were tested for CFTR genotype at screening; eligible patients had to have the F508del-CFTR mutation on bo
47 el, single-arm, first-in-man phase 1 dose-escalation study, eligible patients had advanced ALK-positive or ROS1-positive
49 double-blind, parallel-group, randomised, controlled trial, eligible patients had COPD, post-bronchodilator forced expira
50 atients and Methods In this intergroup international trial, eligible patients had surgically resected cutaneous melanoma
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。